NCT07354217Not yet recruitingPhase 4
Workflow Optimization During Pulse Field Ablation for Atrial Fibrillation
Source: ClinicalTrials.gov · Last updated 20 Apr 2026
Brief summary (registry, in English)
To evaluate the efficacy and safety of intravenous lidocaine in reducing diaphragmatic contraction and suppressing the cough reflex during pulsed field ablation procedures.
- Status (registry)
- Not yet recruiting
- Phase (registry)
- Phase 4
- Study type
- Interventional
- Enrollment
- 60 (estimated)
- First submitted
- 6 Jan 2026
- Start date
- 1 Jun 2026
- Primary completion date
- 31 Dec 2030
- Lead sponsor
- National Taiwan University Hospital
- Diseases
- Atrial fibrillation
- NCT number
- NCT07354217
What you commit to
- Study type: Interventional · Phase 4
- Planned participants: 60
- From 1 Jun 2026 to the primary completion date, 31 Dec 2030
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other illness
- Known allergy to study drug lidocaine.
- Underlying significant pulmonary disease, such as asthma or COPD needing long term maintenance therapy or documented interstitial lung disease
Other
- Informed consent could not be obtained
- Presence of thrombus in the LA or LA appendage
Who the study is looking for
- Patients with paroxysmal or persistent AF and are scheduled to undergo PVI.
- Patients who can understand the study aims and protocol and are willing to follow the protocol for one year.
Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| National Taiwan University Hospita Coordinator of this site? Confirm its status | Taipei | Taiwan | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.